Publicaciones archivos - Página 17 de 20

Comparison of fluorescence in situ hybridization -FISH- and conventional cytology for early detection of urothelial carcinoma

Nadina Erill ¹, Anna Colomer ^1, Míriam Gorriz ^1,2, Naim Hannaoui ³, Ruth Román ¹, Maria Conangla ², Josep M Banús ³, Carlos Cordon-Cardo ⁴, Xavier Puig ^1,2.

¹BIOPAT, Grup Assistència, Barcelona, Spain; ²HISTOPAT Laboratoris, Barcelona, Spain; ³Institut Català d’Urologia i Nefrologia, ICUN; Barcelona, Spain; and ⁴Division of Molecular Pathology, Memorial Sloan-Kettering Cancer Center, New York, USA.

Bladder tumors have a high recurrence rate, so treated patients are followed for detection of potential new lesions. Cystoscopy and cytology have been the standard […]

Alberto 2004-07-23T17:48:21+00:00

BRAF mutations in colorectal cancer are linked to loss of hMLH1 expression and proximal location, while independent of K-RAS activation

Anna Colomer ¹, Nadina Erill ^1, August Vidal ², Ruth Román ¹, Montse Verdú ^2, Carlos Cordon-Cardo ³, Xavier Puig ^1,2.

¹BIOPAT, Grup Assistència, Barcelona, Spain; ²HISTOPAT Laboratoris, Barcelona, Spain; ³Division of Molecular Pathology, Memorial Sloan-Kettering Cancer Center, New York^.

The RAF gene family encodes RAS-regulated kinases that mediate cellular responses to growth signals. Mutations within the BRAF gene occur in about 10% of colorectal cancers, and are significantly associated to defective mismatch repair (MMR) due […]

Alberto 2004-07-23T17:02:21+00:00

Hibridació in situ Fluorescent -FISH- en la detecció del carcinoma urotelial

N.Erill ^1, A.Colomer ^1, C Pubill ², N. Hannaoui ³, R. Román ^1, M.Conangla², JM. Banús ³, C. Cordón ¹, X. Puig ^1,2.

¹BIOPAT, Grup Assistència; ²HISTOPAT Laboratoris, ³Institut Català d’Urologia i Nefrologia, ICUN; Barcelona.

El carcinoma urotelial de bufeta és un dels tumors malignes més freqüents al nostre entorn. S’associa a una elevada taxa de recurrència, al voltant d’un 80% dels casos, i fins a un 30% pot evolucionar cap a carcinoma invasiu. Actualment, tant el diagnòstic com el seguiment […]

Alberto 2004-06-23T17:46:45+00:00

Genetic and immunophenotype analyses of TP53 in bladder cancer: TP53 alterations are associated with tumor progression

Erill N ¹, Colomer A ¹, Verdú M ², Román R ^1, Condom E ^2, Hannaoui N ^3, Banús JM ^3, Cordón-Cardó C ⁴, and Puig X ^1,2.

¹BIOPAT, Grup Assistència, Barcelona; ²HISTOPAT Laboratoris, Barcelona; ³ICUN, Barcelona; and ⁴Division of Molecular Pathology, Memorial Sloan-Kettering Cancer Center, New York.

Altered p53 status is a frequent event in bladder cancer and reported to have prognostic significance. We studied the TP53gene and its product in 76 patients affected with urinary bladder carcinomas by immunohistochemistry (mAb DO-7), […]

Alberto 2004-02-09T22:14:36+00:00

Biochemical analysis and optimization of inhibition and adsorption phenomena in glass-silicon PCR-chips

I. Erill ^a, S. Campoy ^b, N. Erill ^c, J. Barbé ^b, J. Aguiló ^a

^aBiomedical Applications Group, Centro Nacional de Microelectrónica (CNN.IMB); ^b Departament de Genètica i Microbiologia / Centre de Recerca en Sanitat Animal (CReSA) Universitat Autònoma de Barcelona; ^cBIOPAT. Biopatología molecular. Grup Assistència.

Texto completo

Sensors and Actuators B 96 (2003) 685-692.

Alberto 2003-11-02T17:24:41+00:00

Previous 15 16 17 18 19 Next